Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 80
- Reported
- 75
- Verified
- 68
- Gap
- +12
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Wait for stronger evidence
- Why
- Genuine first-in-class FDA authorization with strong peer-reviewed signal quality, but it is a diagnostic adjunct in very early US commercial rollout (3 patients, 9 centers as of Feb 2026) with a thin installed base — too early to treat as a dependable substrate
- Next
- Track DETECT enrollment and US real-world data through 2026-2027; revisit once multi-center US clinical-utility outcomes and stable reimbursement are demonstrated beyond the initial epilepsy-center rollout
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 1
- Tier 2
- 1
- Tier 3
- 4
- Supports
- 4
- Contradicts
- 1
- Context
- 1
- Latest observed
- 2026-02-25
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.